These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30619776)

  • 1. Commentary: The Influence of Proton Pump Inhibitors on the Fecal Microbiome of Infants with Gastroesophageal Reflux-A Prospective Longitudinal Interventional Study.
    Drall KM; Tun HM; Kozyrskyj AL
    Front Cell Infect Microbiol; 2018; 8():430. PubMed ID: 30619776
    [No Abstract]   [Full Text] [Related]  

  • 2. The Influence of Proton Pump Inhibitors on the Fecal Microbiome of Infants with Gastroesophageal Reflux-A Prospective Longitudinal Interventional Study.
    Castellani C; Singer G; Kashofer K; Huber-Zeyringer A; Flucher C; Kaiser M; Till H
    Front Cell Infect Microbiol; 2017; 7():444. PubMed ID: 29075620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Streptococcus agalactiae meningoencephalitis associated with gastroesophageal reflux disease and chronic proton pump inhibitors use, in a 9 month-old infant: a case report.
    Bîrluţiu V; Luca CM; Bîrluțiu RM
    BMC Pediatr; 2018 Feb; 18(1):21. PubMed ID: 29390957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Proton Pump Inhibitors and their Microbiome-Mediated Side Effects].
    Horvath A; Stadlbauer V
    Zentralbl Chir; 2021 Apr; 146(2):165-169. PubMed ID: 33327006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease.
    Higginbotham TW
    Ann Pharmacother; 2010 Mar; 44(3):572-6. PubMed ID: 20124466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ANTISECRETORY TREATMENT FOR PEDIATRIC GASTROESOPHAGEAL REFLUX DISEASE - A SYSTEMATIC REVIEW.
    Mattos ÂZ; Marchese GM; Fonseca BB; Kupski C; Machado MB
    Arq Gastroenterol; 2017 Dec; 54(4):271-280. PubMed ID: 28954042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of gut microbiota in Clostridium difficile infection.
    Samarkos M; Mastrogianni E; Kampouropoulou O
    Eur J Intern Med; 2018 Apr; 50():28-32. PubMed ID: 29428498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of proton pump inhibitors and other commonly used medication on the gut microbiota.
    Imhann F; Vich Vila A; Bonder MJ; Lopez Manosalva AG; Koonen DPY; Fu J; Wijmenga C; Zhernakova A; Weersma RK
    Gut Microbes; 2017 Jul; 8(4):351-358. PubMed ID: 28118083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastroesophageal Reflux Disease.
    Kellerman R; Kintanar T
    Prim Care; 2017 Dec; 44(4):561-573. PubMed ID: 29132520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are proton pump inhibitors indicated for the treatment of gastroesophageal reflux in infants and children?
    Rudolph CD
    J Pediatr Gastroenterol Nutr; 2003; 37 Suppl 1():S60-4. PubMed ID: 14685080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of once-daily esomeprazole for the treatment of gastroesophageal reflux disease in neonatal patients.
    Davidson G; Wenzl TG; Thomson M; Omari T; Barker P; Lundborg P; Illueca M
    J Pediatr; 2013 Sep; 163(3):692-8.e1-2. PubMed ID: 23800403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD.
    Baumeler L; Papakonstantinou E; Milenkovic B; Lacoma A; Louis R; Aerts JG; Welte T; Kostikas K; Blasi F; Boersma W; Torres A; Rohde GG; Boeck L; Rakic J; Scherr A; Tamm M; Stolz D
    Respirology; 2016 Jul; 21(5):883-90. PubMed ID: 26970108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease.
    Yadlapati R; DeLay K
    Med Clin North Am; 2019 Jan; 103(1):15-27. PubMed ID: 30466671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy of proton pump inhibitor therapy in neurologically impaired children with gastroesophageal reflux: prospective study.
    Cheung KM; Tse PW; Ko CH; Chan YC; Leung CY; Chan KH
    Hong Kong Med J; 2001 Dec; 7(4):356-9. PubMed ID: 11773669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refractory gastroesophageal reflux disease.
    Moraes-Filho JP
    Arq Gastroenterol; 2012 Dec; 49(4):296-301. PubMed ID: 23329226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of pediatric gastroesophageal reflux disease and proton pump inhibitor therapy.
    Colletti RB; Di Lorenzo C
    J Pediatr Gastroenterol Nutr; 2003; 37 Suppl 1():S7-S11. PubMed ID: 14685071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
    Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
    PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton Pump Inhibitors May Not Be the First Line of Treatment for GERD in Infants.
    Gunasekaran T; Kakodkar S; Berman JH
    J Pediatr Gastroenterol Nutr; 2018 Jan; 66(1):e26. PubMed ID: 28953523
    [No Abstract]   [Full Text] [Related]  

  • 19. No effect of proton pump inhibitors on crying and irritability in infants: systematic review of randomized controlled trials.
    Gieruszczak-Białek D; Konarska Z; Skórka A; Vandenplas Y; Szajewska H
    J Pediatr; 2015 Mar; 166(3):767-70.e3. PubMed ID: 25556017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton pump inhibitor use in infants: FDA reviewer experience.
    Chen IL; Gao WY; Johnson AP; Niak A; Troiani J; Korvick J; Snow N; Estes K; Taylor A; Griebel D
    J Pediatr Gastroenterol Nutr; 2012 Jan; 54(1):8-14. PubMed ID: 21946832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.